Robert L. Scott, M.D., Ph.D.

  1. Cardiologist
  1. Kamel MA, Scalia IG, Badr AT, Baba Ali N, Farina JM, Pereyra M, Abbas MT, Mahmoud AK, Scott RL, Steidley DE, Rosenthal JL, Lemond LM, Sell-Dottin KA, Hardaway BW, Barry T, Yang M, Chao CJ, Jokerst CE, Ayoub C, Arsanjani R. Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities. J Cardiovasc Dev Dis. 2024 Mar 21; 11 (3)
    View PubMed
  2. Mahmoud AK, Abbas MT, Kamel MA, Farina JM, Pereyra M, Scalia IG, Barry T, Chao CJ, Marcotte F, Ayoub C, Scott RL, Majdalany DS, Arsanjani R. Current Management and Future Directions for Pulmonary Arterial Hypertension Associated with Congenital Heart Disease. J Pers Med. 2023 Dec 20; 14 (1)
    View PubMed
  3. Asleh R, Vucicevic D, Petterson TM, Kremers WK, Pereira NL, Daly RC, Edwards BS, Steidley DE, Scott RL, Kushwaha SS. Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study. J Clin Med. 2022 Jan 10; 11 (2)
    View PubMed
  4. Agasthi P, Smith SD, Murphy KM, Buras MR, Golafshar M, Herner M, Anand S, Pujari S, Allam MN, Mookadam F, Hardaway B, Scott RL, DeValeria PA, Venepally NR, Arsanjani R. Artificial Intelligence Helps Predict 5-year Mortality and Graft Failure in Patients Undergoing Orthotopic Heart Transplantation. J Heart Lung Transplant. 2020 Apr; 39 (4S):S142 Epub 2020 Mar 30
    View PubMed
  5. Schmidt AF, Holmes MV, Preiss D, Swerdlow DI, Denaxas S, Fatemifar G, Faraway R, Finan C, Valentine D, Fairhurst-Hunter Z, Hartwig FP, Horta BL, Hypponen E, Power C, Moldovan M, van Iperen E, Hovingh K, Demuth I, Norman K, Steinhagen-Thiessen E, Demuth J, Bertram L, Lill CM, Coassin S, Willeit J, Kiechl S, Willeit K, Mason D, Wright J, Morris R, Wanamethee G, Whincup P, Ben-Shlomo Y, McLachlan S, Price JF, Kivimaki M, Welch C, Sanchez-Galvez A, Marques-Vidal P, Nicolaides A, Panayiotou AG, Onland-Moret NC, van der Schouw YT, Matullo G, Fiorito G, Guarrera S, Sacerdote C, Wareham NJ, Langenberg C, Scott RA, Luan J, Bobak M, Malyutina S, Pajak A, Kubinova R, Tamosiunas A, Pikhart H, Grarup N, Pedersen O, Hansen T, Linneberg A, Jess T, Cooper J, Humphries SE, Brilliant M, Kitchner T, Hakonarson H, Carrell DS, McCarty CA, Lester KH, Larson EB, Crosslin DR, de Andrade M, Roden DM, Denny JC, Carty C, Hancock S, Attia J, Holliday E, Scott R, Schofield P, O'Donnell M, Yusuf S, Chong M, Pare G, van der Harst P, Said MA, Eppinga RN, Verweij N, Snieder H, Christen T, Mook-Kanamori DO, Gustafsson S, Lind L, Ingelsson E, Pazoki R, Franco O, Hofman A, Uitterlinden A, Dehghan A, Teumer A, Baumeister S, Dorr M, Lerch MM, Volker U, Volzke H, Ward J, Pell JP, Meade T, Christophersen IE, Maitland-van der Zee AH, Baranova EV, Young R, Ford I, Campbell A, Padmanabhan S, Bots ML, Grobbee DE, Froguel P, Thuillier D, Roussel R, Bonnefond A, Cariou B, Smart M, Bao Y, Kumari M, Mahajan A, Hopewell JC, Seshadri S, Dale C, Costa RPE, Ridker PM, Chasman DI, Reiner AP, Ritchie MD, Lange LA, Cornish AJ, Dobbins SE, Hemminki K, Kinnersley B, Sanson M, Labreche K, Simon M, Bondy M, Law P, Speedy H, Allan J, Li N, Went M, Weinhold N, Morgan G, Sonneveld P, Nilsson B, Goldschmidt H, Sud A, Engert A, Hansson M, Hemingway H, Asselbergs FW, Patel RS, Keating BJ, Sattar N, Houlston R, Casas JP, Hingorani AD, Lifelines Cohort authors//ICBP Consortium//METASTROKE Consortium of the ISGC. Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9. BMC Cardiovasc Disord. 2019 Oct 29; 19 (1):240
    View PubMed
  6. Jahanyar J, Liao JM, DeValeria P, Steidley DE, Craner R, Ramakrishna H, Scott RL. Early Postoperative Aortic Root Thrombus After Heartmate 3. Heart Surg Forum. 2019 Sep 5; 22 (5):E372-E374 Epub 2019 Sept 05
    View PubMed
  7. Chakkera HA, Angadi SS, Heilman RL, Kaplan B, Scott RL, Bollempalli H, Cha SS, Khamash HA, Huskey JL, Mour GK, Sukumaran Nair S, Singer AL, Reddy KS, Mathur AK, Moss AA, Hewitt WR Jr, Qaqish I, Behmen S, Keddis MT, Unzek S, Steidley DE. Cardiorespiratory Fitness (Peak Oxygen Uptake): Safe and Effective Measure for Cardiovascular Screening Before Kidney Transplant. J Am Heart Assoc. 2018 May 31; 7 (11)
    View PubMed
  8. Nokes BT, Pajaro O, Stephen J, DeValeria P, Scott R, Shah S, Steidley E, Jahanyar J. Monster Lung Cavity in a Heart Transplant Recipient. Heart Surg Forum. 2018 Mar 05; 21(2):E072-E074.
    View PubMed
  9. Medina-Gomez C, Kemp JP, Trajanoska K, Luan J, Chesi A, Ahluwalia TS, Mook-Kanamori DO, Ham A, Hartwig FP, Evans DS, Joro R, Nedeljkovic I, Zheng HF, Zhu K, Atalay M, Liu CT, Nethander M, Broer L, Porleifsson G, Mullin BH, Handelman SK, Nalls MA, Jessen LE, Heppe DHM, Richards JB, Wang C, Chawes B, Schraut KE, Amin N, Wareham N, Karasik D, Van der Velde N, Ikram MA, Zemel BS, Zhou Y, Carlsson CJ, Liu Y, McGuigan FE, Boer CG, Bonnelykke K, Ralston SH, Robbins JA, Walsh JP, Zillikens MC, Langenberg C, Li-Gao R, Williams FMK, Harris TB, Akesson K, Jackson RD, Sigurdsson G, den Heijer M, van der Eerden BCJ, van de Peppel J, Spector TD, Pennell C, Horta BL, Felix JF, Zhao JH, Wilson SG, de Mutsert R, Bisgaard H, Styrkarsdottir U, Jaddoe VW, Orwoll E, Lakka TA, Scott R, Grant SFA, Lorentzon M, van Duijn CM, Wilson JF, Stefansson K, Psaty BM, Kiel DP, Ohlsson C, Ntzani E, van Wijnen AJ, Forgetta V, Ghanbari M, Logan JG, Williams GR, Bassett JHD, Croucher PI, Evangelou E, Uitterlinden AG, Ackert-Bicknell CL, Tobias JH, Evans DM, Rivadeneira F. Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects. Am J Hum Genet. 2018 Jan 4; 102 (1):88-102
    View PubMed
  10. Lohrmann GM, Vucicevic D, Lawrence R, Steidley DE, Scott RL, Kusne S, Blair JE. Single-center experience of antifungal prophylaxis for coccidioidomycosis in heart transplant recipients within an endemic area. Transpl Infect Dis. 2017 Oct; 19 (5) Epub 2017 Aug 07
    View PubMed
  11. Callisen H, Sen A, Lanza L, Patel B, Cubillo E, Gushue L, Libricz S, Jahanyar J, Farmer JC, Scott R. Management of Acute Mechanical Mitral Valve Thrombosis With Venoarterial Extracorporeal Membrane Oxygenation (ECMO). J Cardiothorac Vasc Anesth. 2017 Feb; 31 (1):240-242 Epub 2016 May 07
    View PubMed
  12. Painter JN, O'Mara TA, Marquart L, Webb PM, Attia J, Medland SE, Cheng T, Dennis J, Holliday EG, McEvoy M, Scott RJ, Ahmed S, Healey CS, Shah M, Gorman M, Martin L, Hodgson SV, Beckmann MW, Ekici AB, Fasching PA, Hein A, Rubner M, Czene K, Darabi H, Hall P, Li J, Dork T, Durst M, Hillemanns P, Runnebaum IB, Amant F, Annibali D, Depreeuw J, Lambrechts D, Neven P, Cunningham JM, Dowdy SC, Goode EL, Fridley BL, Winham SJ, Njolstad TS, Salvesen HB, Trovik J, Werner HM, Ashton KA, Otton G, Proietto A, Mints M, Tham E, Bolla MK, Michailidou K, Wang Q, Tyrer JP, Hopper JL, Peto J, Swerdlow AJ, Burwinkel B, Brenner H, Meindl A, Brauch H, Lindblom A, Chang-Claude J, Couch FJ, Giles GG, Kristensen VN, Cox A, Pharoah PD, Tomlinson I, Dunning AM, Easton DF, Thompson DJ, Spurdle AB, AOCS Group//for RENDOCAS//National Study of Endometrial Cancer Genetics Group (NSECG)//Australian National Endometrial Cancer Study Group (ANECS). Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer. Cancer Epidemiol Biomarkers Prev. 2016 Nov; 25 (11):1503-1510 Epub 2016 Aug 22
    View PubMed
  13. Schleifer JW, Mookadam F, Kransdorf EP, Nanda U, Adams JC, Cha S, Pajaro OE, Steidley DE, Scott RL, Carvajal T, Saadiq RA, Srivathsan K. Effect of Continued Cardiac Resynchronization Therapy on Ventricular Arrhythmias After Left Ventricular Assist Device Implantation. Am J Cardiol. 2016 Aug 15; 118 (4):556-9 Epub 2016 May 28
    View PubMed
  14. Abudiab MM, Hakim FA, Fortuin DF, Scott RL. Anomalous coronary artery in a transplanted heart: a rare incidental diagnosis. J Saudi Heart Assoc. 2016 Jan; 28 (1):46-8 Epub 2015 June 18
    View PubMed
  15. Unzueta A, Valdez R, Chang YH, Desmarteau YM, Heilman RL, Scott RL, Douglas DD, Rakela J. Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation. Ann Hepatol. 2016 Jan-Feb; 15 (1):33-40
    View PubMed
  16. Unzueta A, Valdez R, Chang YH, Desmarteau YM, Heilman RL, Scott RL, Douglas DD, Rakela J. Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation. Ann Hepatol. 2016 Jan - Feb; 15 (1):33-40
    View PubMed
  17. Kalya A, Jaroszewski D, Pajaro O, Scott R, Gopalan R, Kasper D, Arabia F. Role of total artificial heart in the management of heart transplant rejection and retransplantation: case report and review. Clin Transplant. 2013 Jul-Aug; 27(4):E348-50. Epub 2013 May 31.
    View PubMed
  18. Webb BJ, Blair JE, Kusne S, Scott RL, Steidley DE, Arabia FA, Vikram HR. Concurrent pulmonary Aspergillus fumigatus and mucor infection in a cardiac transplant recipient: a case report. Transplant Proc. 2013 Mar; 45(2):792-7. Epub 2012 Sep 15.
    View PubMed
  19. Nelson MR, Lanza LA, Reeder CB, Scott RL, McCullough AE, Chandrasekaran K, Click RL. Histologic remission of cardiac amyloidosis: a case report. Amyloid. 2012 Jun; 19: (2)106-9.
    View PubMed
  20. Gopalan R, Scott R, Arabia F, Chandrasekaran K. Electro-acupuncture therapy in a patient with a total artificial heart. Acupunct Med. 2011 Dec; 29(4):302-3. Epub 2011 Nov 04.
    View PubMed
  21. Jaroszewski DE, Kleisli T, Staley L, Pierce C, Scott R, Steidley DE, DeValeria P, Arabia FA. A traveling team concept to expedite the transfer and management of unstable patients in cardiopulmonary shock. J Heart Lung Transplant. 2011 Jun; 30 (6):618-23 Epub 2011 Jan 15
    View PubMed
  22. Pajaro OE, Jaroszewski DE, Scott RL, Kalya AV, Tazelaar HD, Arabia FA. Antibody-mediated rejection in heart transplantation: case presentation with a review of current international guidelines. J Transplant. 2011; 2011:351950 Epub 2011 Dec 06
    View PubMed
  23. Eleid MF, Caracciolo G, Cho EJ, Scott RL, Steidley DE, Wilansky S, Arabia FA, Khandheria BK, Sengupta PP. Natural history of left ventricular mechanics in transplanted hearts: relationships with clinical variables and genetic expression profiles of allograft rejection. JACC Cardiovasc Imaging. 2010 Oct; 3 (10):989-1000
    View PubMed
  24. Staley LL, Dobberpuhl J, Pierce CN, Scott RL, Jaroszewski DE, Arabia FA. Bridge to decision: SWAT team approach used by Mayo Clinic Arizona's cardiac transport team. Prog Transplant. 2010 Jun; 20 (2):118-24
    View PubMed
  25. Cho EJ, Caracciolo G, Khandheria BK, Steidley DE, Scott R, Abhayaratna WP, Chandrasekaran K, Sengupta PP. Tissue Doppler image-derived measurements during isovolumic contraction predict exercise capacity in patients with reduced left ventricular ejection fraction. JACC Cardiovasc Imaging. 2010 Jan; 3 (1):1-9
    View PubMed
  26. Jaroszewski DE, Marranca MC, Pierce CN, Wong RK, Steidley ED, Scott RL, Devaleria PA, Arabia F. Successive circulatory support stages: a triple bridge to recovery from fulminant myocarditis. J Heart Lung Transplant. 2009 Sep; 28(9):984-6.
    View PubMed
  27. Gastwirth VG, Yang HS, Steidley DE, Scott RL, Chandrasekaran K. Dobutamine stress-induced cardiomyopathy in an orthotopic heart transplant patient. J Heart Lung Transplant. 2009 Sep; 28(9):968-70.
    View PubMed
  28. Scott RL. Angiotensin-converting enzyme inhibitor and/or angiotensin receptor antagonist for the postmyocardial infarction patient. Cardiol Clin. 2008 Feb; 26(1):73-7, vii.
    View PubMed
  29. Mehra MR, Milani R, Richie M, Uber PA, Park MH, Ventura HO, Scott RL, Lavie CJ. Ventricular-vascular uncoupling increases expression of B-type natriuretic peptide in heart transplantation. Transplant Proc. 2004 Dec; 36(10):3149-51.
    View PubMed
  30. Mehra MR, Uber PA, Park MH, Ventura HO, Scott R. Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: clinical and neurohormonal benefits. Transplant Proc. 2004 Dec; 36(10):3152-5.
    View PubMed
  31. Park MH, Scott RL, Uber PA, Ventura HO, Mehra MR. Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension. Congest heart Fail. 2004 Sep-Oct; 10(5):221-5.
    View PubMed
  32. Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris BC, Frohlich ED. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol. 2004 May; 43(9):1590-1595.
    View PubMed
  33. Mehra MR, Uber PA, Ventura HO, Scott RL, Park MH. The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol. 2004; 43:806-810.
    View PubMed
  34. Mehra MR, Uber PA, Potluri S, Ventura HO, Scott RL, Park MH. Usefulness of an elevated B-type natriuretic peptide allograft failure, cardiac allograft vasculopathy and survival after heart transplantation. Am J Cardiol. 2004; 94(4):454-458.
    View PubMed
  35. Alaeddini J, Uber PA, Park MH, Scott RL, Ventura HO, Mehra MR. Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure. Am J Cardiol. 2004; 94(11):1475-1477.
    View PubMed
  36. Park MH, Uber PA, Scott RL, Mehra MR. B-type natriuretic peptide in heart transplantation: an important marker of allograft performance. Heart Fail Rev. 2003 Oct; 8(4):359-63.
    View PubMed
  37. Scott RL. Is heart failure in African Americans a distinct entity? Congest Heart Fail /Aug. 2003 Jul; 9:193-196.
  38. Alaeddini J, Uber P, Park MH, Scott RL, Mehra MR. Difficult cases in heart failure: sildenafil and assessment of pulmonary arterial reactivity in heart failure. Congest Heart Fail /June. 2003 May; 9:176-178.
  39. Mehra MR, Ventura HO, Uber PA, Scott RL, Park MH. Is all intimal proliferation created equal in cardiac allograft vasculopathy? The Quantity-Quality Paradox J Heart Lung Transplant. 2003 Feb; 22(2):118-123.
  40. Uber PA, Mehra MR, Park MH, Scott RL. Clopidogrel and rhabdomyolysis following heart transplantation. J Heart Lung Transplant. 2003; 22:107-108.
    View PubMed
  41. Mehra MR, Uber PA, Uber WE, Scott RL, Park MH. Allosensitization in heart transplantation: implications and management strategies. Curr Opin Cardiol. 2003; 18(2):153-158.
    View PubMed
  42. Mehra MR, Uber PA, Park MH, Scott RL. Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. Transplantation. 2002 Dec; 74(11):1568-73.
    View PubMed
  43. Park MH, Scott RL, Uber PA, Harris BC, Chambers R, Mehra MR. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am J Card. 2002 Dec; 90(12):1326-1329.
    View PubMed
  44. Mehra MR, Uber PA, Vivekananthan K, Solis S, Scott RL, Park MH, Milani RV, Lavie CJ. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. J Am Coll Card. 2002 Nov; 40(9):1609-14.
  45. Park MH, Scott RL, Uber PA, Mehra MR. Treatment of pulmonary hypertension: a promising new age. Catheter Cardiovasc Interv. 2002 Nov; 57(3):395-403.
    View PubMed
  46. Vivekananthan K, Kalapura T, Mehra MR, Lavie CJ, Milani RV, Scott RL, Park MH. Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. Am J Card. 2002 Sep 1; 90(5):517.
    View PubMed
  47. Uber PA, Mehra MR, Harris B, Scott RL, Park MH. Steroid weaning in heart transplantation is associated with decreased B-type natriuretic peptide: surrogate evidence for cardiac adaptation. Transplant Proc. 2002 Aug; 34(5):1843.
    View PubMed
  48. Mehra MR, Uber PA, Scott RL, Park MH, Milani RV. The effect of immunosuppressive regimen on novel markers of atherothrombosis in heart transplantation: homocysteine, C-reactive protein, and mean platelet volume. Transplant Proc. 2002 Aug; 34(5):1866.
    View PubMed
  49. Sangha SS, Uber PA, Park MH, Scott RL, Mehra MR. Difficult cases in heart failure: the challenge of neurocognitive dysfunction in severe heart failure. Congest Heart Fail. 2002 Jul-Aug; 8(4):232-4.
    View PubMed
  50. Park MH, Scott RL, Uber PA, Mehra MR. Bedside B-type natriuretic peptide and acute non-cellular cardiac allograft rejection. J Heart & Lung Transplant. 2002 May; 21(5):613-4.
  51. Mehra MR, Uber PA, Uber WE, Park MH, Scott RL. Anything but a biopsy: non-invasive monitoring for cardiac allograft rejection. Curr Opin Cardiol. 2002 Mar; 17(2):131-136.
    View PubMed
  52. Grant A 3rd, Uber PA, Park MH, Scott RL, Mehra MR. Difficult cases in heart failure. Novel diagnostic markers in heart failure: an emerging paradigm shift? Congest Heart Fail. 2001 Sep-Oct; 7(5):274-276.
    View PubMed
  53. Scott RL. Native mitral valve regurgitation. Proactive management can improve outlook. Postgrad Med. 2001 Aug; 110(2):57-63; quiz 2.
    View PubMed
  54. Scott RL, Ratliff NB, Starling RC, Young JB. Recurrence of giant cell myocarditis in cardiac allograft. J Heart Lung Transplant. 2001 Mar; 20(3):375-80.
    View PubMed
  55. Uber PA, Mehra MR, Scott RL, Prasad AK, Park MH. Ethnic disparities in the pharmacologic characteristics of tacrolimus in heart transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1581-2.
    View PubMed
  56. Mehra MR, Uber PA, Park MH, Prasad AK, Scott RL. A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients. Transplant Proc. 2001 Feb-Mar; 33(1-2):1606-7.
    View PubMed
  57. Mehra MR, Uber PA, Scott RL, Prasad AK, Park MH. Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation. Transplant Proc. 2001 Feb-Mar; 33(1-2):1613-4.
    View PubMed
  58. Mehra MR, Uber PA, Prasad AK, Park MH, Scott RL, McFadden PM, Van Meter CH. Long-term outcome of cardiac allograft vasculopathy treated by transmyocardial laser revascularization: early rewards, late losses. J Heart Lung Transplant. 2000 Aug; 19(8):801-804.
    View PubMed
  59. Prasad A, Mehra MR, Park MH, Scott RL, Uber PA, McFadden PM. Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease. Ann Thorac Surg. 1999 Nov; 68(5):1840-1.
    View PubMed
  60. Malik FS, Mehra MR, Uber PA, Park MH, Scott RL, Van Meter CH. Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock. J Card Fail. 1999 Mar; 5(1):31-7.
    View PubMed
  61. Stone WL, Henderson RA, Howard GH, Hollis AL, Payne PH, Scott RL. The role of antioxidant nutrients in preventing hyperbaric oxygen damage to the retina. Free Radical Biology & Medicine. 1989; 6:505-512.
    View PubMed